LE16053 Healthy Volunteer Trial

CONDITION

GENDER

Both males and females

AGE GROUP

From 18

to 50 years

STATUS

Closed: follow-up continuing

This is an open label, phase I study assessing the safety and tolerability of a pharmaceutical formulation comprising a protein that is being developed as a treatment for acute ischemic stroke.

Eligible participants will be required to stay in the clinical unit for a total of 4 nights and 5 days.

Participants must meet the following criteria:

Male or Female between the ages of 18 and 50
BMI must be between 18 – 30 kg/m2
Medication free with no allergies to any drugs
Non-smokers
Free from any clinically significant illness or disease as determined by medical history

Remuneration is offered to eligible participants.

Click here to register for our clinical trials.

CONTACT DETAILS

Clinical Trial Site: Linear Clinical Research Ltd
Phone Number: 0863825100 Email: contactus@linear.org.au Location: Hospital Avenue, Nedlands, Western Australia, Australia

Studies Contact Form

  • Hidden

Approved By: HREC              

Clinical Trial Registry Link: